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UbiquitinationRadiation induces cell cycle arrest and/or cell death inmammalian cells. In the present study, we show that Hip2,
a ubiquitin-conjugating enzyme, can overcome radiation-induced G2/M cell cycle arrest and trigger the entry
into mitosis. Ionizing radiation increased the levels of Hip2 by preventing its degradation but not its gene
transcription. The stability of Hip2 in irradiated cells was further conﬁrmed using live cell ﬂuorescence imaging.
Flow cytometric andmolecular analyses revealed that Hip2 abrogated radiation-inducedG2/M arrest, promoting
entry into mitosis. Bimolecular ﬂuorescence complementation assays and co-immunoprecipitation experiments
showed that Hip2 interacted with and targeted p53 for degradation via the ubiquitin proteasome system,
resulting in the activation of cdc2-cyclin B1 kinase to promote mitotic entry. These results contribute to our un-
derstanding of the mechanisms that regulate cell cycle progression and DNA damage-induced G2/M checkpoint
cellular responses.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Eukaryotic cell cycle progression is regulated by several conserved
proteins including cyclins [1,2]. In response to DNA damage, mammalian
cells induce cell cycle arrest, thereby allowing the damaged chromo-
somes to be repaired before the cells enter into the mitosis (M) phase
[3,4]. A pivotal molecule involved in DNA damage-induced G2/M
checkpoint cellular responses is the tumor suppressor p53, which is a
short-lived protein that is mutated in more than 50% of human cancers
[5,6]. The p53 protein is rapidly stabilized in response to DNA damage
such as that caused by ionizing radiation, etoposide, and UV light. The
p53-mediated cell cycle arrest involves the transactivation of its target
genes, including p21/Cip1, GADD45, 14-3-3σ, or the suppression of cdc2
and cyclin B1 gene expression [7,8]. Once activated by the DNA damage
signal, p53 inhibits cdc2-cyclin B1 kinase activity to prevent the entry
of damaged chromosomes into mitosis. The present study examines
the role of Hip2 in overcoming G2/M arrest.
Hip2/E2-25K is a ubiquitin-conjugating enzyme (E2) that interacts
with huntingtin, a protein linked to Huntington's disease [9], and is
highly expressed in the frontal cortex and striatum. The Hip2 protein
alsomediates amyloid-βpeptide (Aβ) neurotoxicity,which is associated
with the neurodegeneration of Alzheimer's disease (AD) [10]. In a recentis original research.
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staurosporine and Smac, or by overexpression of cyclin B1 [11,12]. The
Hip2 gene shows high similarity to the UBC-1 gene of Saccharomyces
cerevisiae [13]. Hip2 is involved in the APC (anaphase-promoting
complex)-dependent assembly of K-48 linked polyubiquitin chains in
mammalian cells [14], and it plays an important role in the synthesis
of K-48 linked multi-ubiquitin chains in the absence of E3 ligases [15].
The present study shows that Hip2 can overcome radiation-induced
G2/M cell cycle arrest by targeting p53 for degradation via the ubiquitin
proteasome system. The results of our study suggest the existence of a
novelmechanism to overcomeG2/M arrest caused by ionizing radiation.
2. Materials and methods
2.1. Reagents
MG-132 was purchased from Calbiochem and cycloheximide (CHX)
and nocodazole were obtained from Sigma. Monoclonal antibodies
against p53, cdc2, andHA, and polyclonal antibodies against GST and cy-
clin B1were purchased from Santa Cruz Biotechnology; anti p-cdc2 and
Hip2 antibodies were from Cell Signaling; anti p-H3 antibodies were
fromUpstate and anti-p21 antibodywas from BD Biosciences, Clontech.
2.2. Plasmids, transfection, and cell culture
Full length cDNA encodingHip2was ampliﬁed using the polymerase
chain reaction (PCR) and cloned into the pCMV-HA vector digested
with HindIII and EcoRI. The pCMV-Flag-5bHip2 (S86Y) vector, which
contains a core domain mutation (S86Y) that selectively inactivates
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Y.K. Jung (Seoul National University, Seoul). Hip2 (S86Y)was subcloned
into the pCMV-HA vector digested with HindIII and EcoRI. The
pBluescriptII Hip2 construct was subcloned into pcDNA-GST digested
with BamH1 and EcoRI. pcDNA-p53 was described in a previous study
(27). HEK293 and HEK293T cells were maintained in Dulbecco's modi-
ﬁed Eagle's medium supplemented with 8% fetal bovine serum (FBS),
streptomycin (100 μg/ml), and penicillin (100 U/ml) (Gibco–BRL).
HCT116 (p53+/+) cells were maintained in McCoy's 5A medium
supplemented with 10% FBS, streptomycin (100 μg/ml), and penicillin
(100 U/ml) (Welgene). The PEI method was used according to the
manufacturer's instructions (Sigma) to transfect various plasmids into
HEK293, HEK293T, or HeLa cells. HCT116 cells were transfected with
various plasmids by using the TurboFect method (Fermentas).
2.3. Irradiation
Cultured cells were exposed to γ-irradiation for 85 s or 135 s with
the 137Cs γ-irradiator (Atomic Energy of Canada, Ltd, Canada) before
analysis.
2.4. Cell cycle analysis
For cell cycle distribution analyses, HEK293 cells were transiently
co-transfected with pcDNA/HA, pcDNA/HA-Hip2, and pcDNA/HA-Hip2Fig. 1. The stability of the Hip2 protein is increased by ionizing radiation. (A) HEK293 cells
were exposed to various doses of radiation up to 5 Gy. Cells were harvested and equal
amounts of protein (30 μg)were separated by SDS-PAGE and transferred to nitrocellulose
membranes. Hip2was detected using polyclonal anti-Hip2 antibody and actinwas used as
a loading control (top panel). (B) HEK293 cells were irradiated with 5 Gy. Proteins were
harvested at the indicated times. Western blot analysis was performed under the same
conditions as in (A, top panel) (bottom panel). (C) HEK293 cells were treated with
50 μg/ml cycloheximide (CHX) and incubated for the indicated times. Proteins in the
cell lysates were resolved by SDS-PAGE and transferred to nitrocellulose membranes.
Hip2 was detected with anti-Hip2 antibody and actin was used as a loading control.
(D) HEK293 cells were irradiated with 5 Gy and treated with 50 μg/ml cycloheximide
followed by incubation for the indicated times. Hip2 proteins were detected by Western
blot analysis as in (C). (E) Quantiﬁcation of the band intensities of the immunoblots
shown in panels C and D was performed using Multi-Gauge image analysis software.
Values represent means ± SD of three independent experiments. (F) Hip2 stability in
irradiated cells was conﬁrmedwith ﬂuorescence images. HeLa cells transfectedwith plas-
mids expressing EGFP-Hip2were irradiated. Cellswere further cultured for 2 h inmedium
with 100 μg/ml of cycloheximide, and then visualized by Confocal Microscopy (LSM700)
with live cell imaging chambers (Carl Zeiss). Fluorescence intensity of EGFP-Hip2 was
analyzed with the program Zen Light 2011 (Carl Zeiss). The intensities of 10 regions of
non-irradiated or irradiated cells were averaged and compared to the intensity measured
0 min after CHX treatment. The scale bar represents 20 μm.
Fig. 1 (continued).(S86Y). After 24 h, the cells were exposed to 5 Gy irradiation and cul-
tured for 16 h. The cells were then ﬁxed in 70% ethanol at 4 °C for at
least 4 h. The ﬁxed cells were washed once with PBS and then treated
with 10 mg/ml RNase for 30 min at room temperature. After addition
of 10 μl of propidium iodide (5 mg/ml), the samples were incubated
for 10 min at room temperature and analyzed with a FACScan ﬂow
cytometer (BD, Science).
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HEK293T cells were lysed on ice for 1 h with 1 ml of NETN buffer
(50 mM Tris–HCl, pH 8.0, 120 mM NaCl, 1 mM EDTA, 0.5% NP-40,
10 mM NaF, 1 mM DTT, 1 mM PMSF, and 20 μg of aprotinin and
leupeptin). The cell lysates were centrifuged for 20 min at 13,000 ×g
at 4 °C. Protein concentrations were measured using the Bradford re-
agent (Bio-Rad) and BSA as a standard. For co-immunoprecipitation ex-
periments, the cell lysates were incubated with glutathione Sepharose
beads (GE Healthcare) with constant rotation for 12 h at 4 °C. The
beads were washed 3 or 4 times with NETN buffer. The bound proteins
were eluted from the beads with 1× SDS sample buffer, boiled for
5 min, separated by SDS-PAGE, and analyzed by Western blotting
using anti-p53 or anti-GFP antibodies.
2.6. Western blot analysis
HEK293 cells transfected with each plasmid construct were
harvested, washed with cold PBS, and incubated on ice for 30 min
with 50 μl of RIPA buffer [20 mM Tris–HCl (pH 7.5), 150 mM NaCl,
0.1% SDS, 1% Triton X-100, 1% sodium deoxycholate, 1 mM PMSF,Fig. 2.Hip2 overcomes radiation-induced G2/M cell cycle arrest. HEK293 cells were transiently
the cells were irradiatedwith 5 Gy and cultured for an additional 16 h. The expression levels of
was investigated using FACS analysis of DNA fragmentation in propidium iodide-stained nucleand protease inhibitors]. The cell lysates were centrifuged for 15 min
at 13,000 ×g at 4 °C, and the protein content of the supernatant was
determined using the Bradford protein assay (Bio-Rad) and BSA as a
standard. Equal protein amounts (30 μg) were resolved by SDS-PAGE.
The separated proteins were transferred to nitrocellulose membranes
(Schleicher & Schuell) and probed with various antibodies. The pro-
teins were detected using the enhanced chemiluminescence (ECL)
Western blotting system as described by the manufacturer (Santa Cruz
Biotechnology). Band intensities were measured using Multi-Gauge
image analysis software. Each value was normalized relative to the
density of the signals for actin in the same sample. Values represent
means ± SD of three independent experiments.
2.7. RNAi
The following sequences were cloned in this study: shHip2, 5′-
TGGAATCAGACTGAATTAATTCAAGAGATTAATTCAGTCTGATTCCATT
TTTT-3′; and shGFP, 5′-GCT GAC CCT GAA GTT CAT CTT CAA GAG
AGA TGA ACT TCA GGG TCA GCT TTT TT-3′. The pSilencer 1.0-U6
vector (Ambion) encoding the hairpin RNAs was transfected into
HEK293 cells or HCT116 cells using the PEI method (Sigma).co-transfected with pcDNA/HA, pcDNA/HA-Hip2, and pcDNA/HA-Hip2 (S86Y). After 24 h,
wild-type HA-Hip2 and HA-Hip2 (S86Y) are shown in the top panel. Cell cycle distribution
i.
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HEK293T or HCT116 cells were transiently transfected with
pcDNA/HA-Hip2 or pcDNA/HA-Hip2 (S86Y) and pcDNA/Xpress-Ub.
After 24 h, the cells were irradiated with 5 Gy and treated with or
without the proteasome inhibitor MG-132 (10 μM) for an additionalFig. 3. Cell cycle regulators related to the radiation-induced G2/M arrest. (A) HEK293 cells wer
ation doses up to 5 Gy and cultured for an additional 16 h. Cells were harvested and lysateswer
to nitrocellulose membranes. Cyclin B1 was detected using polyclonal anti-cyclin B1 antibody.
and actin as a loading control. Quantiﬁcation of the band intensities of the Western blots show
normalized to the density of the signals for actin in the same sample. Values indicatemeans ± S
using anti-Hip2 antibody (left panel). HEK293 cells were transfected with control shRNA or H
analysiswas performed as in (A) (right panel). Quantiﬁcation of theWestern blotting band inten
represent means ± SD of three independent experiments.5 h. The cells were lysed and the lysate supernatants were pre-
cleared with protein G-sepharose (GE Healthcare) for 1 h at 4 °C.
Immunoprecipitation was carried out overnight at 4 °C with anti-
p53 antibody. After washing four times with NETN buffer, the
precipitated proteins were analyzed by Western blotting against
an anti-ubiquitin antibody.e transfected with pcDNA/HA or pcDNA/HA-Hip2. The cells were exposed to various radi-
e prepared; equal amounts of protein (20 μg)were separated by SDS-PAGE and transferred
The membranes were subsequently probed against the following antibodies: p-cdc2, HA,
n in panel A was performed using Multi-Gauge image analysis software. Each value was
D of three independent experiments. (B) The efﬁciency of Hip2 knock-downwas analyzed
ip2 shRNA. The cells were irradiated with 5 Gy for an additional 16 h and Western blot
sities shown in panel Bwas performed usingMulti-Gauge image analysis software. Values
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To measure the stability of the Hip2 protein in HEK293 cells, cells
were cultured for 24 h and irradiated with 5 Gy. The cells were treated
with 50 μg/ml of cycloheximide (CHX) for various time periods.
Proteins were isolated from cell lysates and subjected to SDS-PAGE,
transferred to a membrane, and then probed with anti-Hip2 and anti-
actin antibodies.Fig. 4. Hip2 is required for mitotic entry following radiation-induced G2/M arrest. (A) HEK293
5 Gy and then treated with 0.2 μg/ml nocodazole for an additional 3 h. After the cells were har
tibodies. Quantiﬁcation of the band intensities of Western blots shown in panel (A) was perfo
independent experiments. (B) The efﬁciency of Hip2 knock-down was assessed using Hip2 a
The cells were irradiated with 5 Gy, cultured for an additional 16 h and then treated with 0.2
was carried out using anti-p-H3 and anti-actin antibodies (right panel). Quantiﬁcation of the
image analysis software. Values represent means ± SD of three independent experiments.2.10. Live cell imaging experiments
To construct plasmids expressing EGFP-Hip2, Hip2 was cloned into
the pEGFP-C2 vector digestedwith EcoRI and BamHI. After 24 h of trans-
fection, HeLa cells were exposed to 3 Gy irradiation, cultured for 2 h in
medium with 100 μg/ml of cycloheximide, and visualized by Confocal
Microscopy (LSM700) with live cell imaging chambers (Carl Zeiss).
The total intensity of EGFP-Hip2 was calculated with the program Zencells were transfected with pcDNA/HA or pcDNA/HA-Hip2. The cells were irradiated with
vested, Western blot analysis was carried out using anti-p-H3, anti-HA, and anti-actin an-
rmed using Multi-Gauge image analysis software. Values represent means ± SD of three
ntibody (left panel). HEK293 cells were transfected with control shRNA or Hip2 shRNA.
μg/ml nocodazole for additional 3 h. After the cells were harvested, Western blot analysis
band intensities of Western blots shown in panel (B) was performed using Multi-Gauge
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full length cDNAs encoding Hip2 and p53 were ampliﬁed by PCR and
cloned into the pBiFC-CC155 and pBiFC-CrN173 vectors (Addgene),
respectively, and digested with EcoRI and KpnI. Approximately 5 × 105
HeLa cells were grown in poly-D lysine coated 35 mm glass-bottomed
dishes (SPL) with 8% FBS, streptomycin (100 μg/ml), and penicillin
(100 U/ml) for 14–16 h. HeLa cells were transfected with 800 ng of
plasmid encoding Hip2 (S86Y) or P53, cultured for 22 h, and then
visualized by Confocal Microscopy (LSM700) with live cell imaging
chambers (Carl Zeiss).
3. Results
3.1. The stability of theHip2 protein is increased following ionizing radiation
Changes in the expression of ubiquitin proteasome system (UPS)-
related proteins in response to ionizing radiation were investigated in
human HEK293 cells. The cells were exposed to various doses of irradi-
ation and then cultured for 16 h. Proteinswere isolated and subjected to
Western blot analysis with various E2 ubiquitin-conjugating enzymes
or E3 ligase antibodies. Ionizing radiation increased the expression
level of the E2 ubiquitin-conjugating enzyme Hip2 in human HEK293Fig. 5. Hip2 regulates the radiation-induced expression of p53. (A) HEK293 cells were
transfected with pcDNA/HA or pcDNA/HA-Hip2. The cells were irradiated with 5 Gy and
then incubated for an additional 16 h. Cell lysates were analyzed by Western blot and
probed with anti-p53 antibody. The membrane was subsequently probed with anti-HA
and anti-actin antibodies. (B) HEK293 cells were transiently transfected with pcDNA/
HA-Hip2 or pcDNA/HA-Hip2 (S86Y). Western blot analysis was performed under the
same conditions as in (A). Quantiﬁcation of the band intensities of the immunoblots
shown in panel B was performed using Multi-Gauge image analysis software. Values
indicate means ± SD of three independent experiments. (C) The efﬁciency of Hip2
knock-down was detected by using anti-Hip2 antibody (left panel). HCT116 cells were
transiently transfected with control shRNA or Hip2 shRNA. Western blot analysis and
quantiﬁcation of the band intensities were performedunder the same conditions as in (B).cells (Fig. 1A), but not that of other UPS-related proteins including
UbcH6 (E2) and RNF2 (E3) (data not shown). The expression level of
the Hip2 protein increased rapidly after receiving 5 Gy irradiation and
reached a maximum level after 4 h (Fig. 1B).
To examinewhether the ionizing radiation-induced increase in Hip2
levels occurs at the mRNA or protein level, HEK293 cells were exposed
to various doses of irradiation, followed by 16 h of culture and isolation
of total mRNA. Hip2 mRNA levels were measured using ﬂuorogenic
real-time PCR. Hip2 mRNA levels did not change with increasing doses
of gamma irradiation in HEK293 cells (Supplementary Fig. 1A), indi-
cating that ionizing radiation does not affect the transcription level
of Hip2 mRNA.
The stability of the Hip2 protein was assessed bymeasuring its half-
life in the presence of cycloheximide, which blocks protein synthesis
in eukaryotic cells. The half-life of Hip2 was less than 60 min (Fig. 1C
and E). Exposure of cells to 5 Gy of irradiation resulted in a signiﬁcant
stabilization of the Hip2 protein, which showed a half-life of more
than 2 h in radiation-treated cells (Fig. 1D and E). These results suggest
that ionizing radiation increases the levels of Hip2 by preventing its
degradation.
To identify the pathwaymediating the degradation of Hip2, HEK293
cells were treated with the protease inhibitors PMSF, leupeptin, and
benzamide, or the proteasome inhibitor MG-132. Degradation of Hip2
was blocked by MG-132 treatment but not by treatment with protease
inhibitors (Supplementary Fig. 1B), suggesting that Hip2 is degradedFig. 6.Hip2 interacts with p53. (A) HEK293T cells were transiently co-transfectedwith ei-
ther pcDNA/GST or pcDNA/GST-Hip2, and pcDNA/p53. After 36 h, the cell lysates were
precipitated with glutathione Sepharose beads for 3 h at 4 °C. The bound proteins were
eluted and subjected to Western blot analysis against anti-p53 antibody. (B) HEK293T
cells were co-transfected with either pcDNA/GST or pcDNA/GST-p53, and pcDNA/GFP-
Hip2. After 36 h, the cell lysates were precipitated with glutathione Sepharose beads for
3 h at 4 °C. The boundproteinswere eluted and subjected toWestern blot analysis against
anti-GFP antibody. (C) Schematic diagram of a typical BiFC assay for visualization of the
Hip2 and p53 interaction. (D) HeLa cells were co-transfected with either pBiFC-CC155-
Hip2 or pBiFC-CC155-Hip2 (S86A), and pBiFC-CrN173-p53, cultured for 22 h, and then
visualized by Confocal Microscopy (LSM700) with live cell imaging chambers.
Fig. 6 (continued).
2917Y. Bae et al. / Biochimica et Biophysica Acta 1833 (2013) 2911–2921via the ubiquitin proteasome pathway. To conﬁrm that the ubiquitin
proteasome system is involved in the degradation of Hip2, HEK293
cells were treated with MG-132 for 1 h before blocking de novo protein
synthesis with cycloheximide. Hip2 was stabilized (Supplementary
Fig. 1C) in a similar pattern to that shown in Fig. 1D and E (these ex-
periments were performed under the same conditions), implying that
ionizing radiation increases the levels of Hip2bypreventing its degrada-
tion and conﬁrming the involvement of the ubiquitin proteasome
pathway.
The stability of Hip2 as a function of time was examined by ﬂuores-
cence live cell imaging. HeLa cells transfected with plasmids containing
EGFP-Hip2 were irradiated and then treated with cycloheximide for
2 h. Fluorescence images of cells were obtained with an LSM700 confo-
cal microscope with live cell imaging chambers. As shown in Fig. 1F,
EGFP-Hip2 levels did not decrease in irradiated cells over a 120 min
period after cycloheximide treatment, whereas a drastic decrease was
observed in non-irradiated cells, conﬁrming that Hip2 is stabilized in
irradiated cells.
3.2. Hip2 overcomes radiation-induced G2/M cell cycle arrest
In response to ionizing radiation, eukaryotic cells undergo cell cycle
arrest, which enables the repair of damaged chromosomes before the
cells progress to mitosis [16]. To examine the possible correlationbetween radiation-induced Hip2 and cell cycle arrest, cell cycle distribu-
tionwas analyzed by ﬂuorescence-activated cell sorting (FACS). HEK293
cells were transfected with pcDNA/HA or pcDNA/HA-Hip2 and exposed
to 5 Gy irradiation. Ionizing radiation induced cycle arrest at the G2/M
phase in negative control vector-transfected cells, as determined by the
higher G2/M fraction in irradiated cells (41%) than in non-irradiated
cells (13%) (Fig. 2A, top panel). However, Hip2-overexpressing cells
showed the capacity to overcome the radiation-induced G2/M arrest
(15%) (Fig. 2A, middle panel).
To conﬁrm this effect further, a mutant Hip2 was generated by re-
placing the active site serine residue by tyrosine. The mutant Hip2
(S86Y), which was devoid of polyubiquitin chain synthesis enzymatic
activity [15], did not overcome the radiation-induced G2/M arrest
(38%), suggesting that this function of Hip2 requires its ubiquitin-
conjugating activity (Fig. 2A, bottom panel).
To examine further the effect of radiation-induced Hip2 on G2/M
cell cycle arrest, shRNA-mediated knock-down experiments were
performed. The colon cancer cell line HCT116 was used for this experi-
ment because of the high expression levels of Hip2 in these cells com-
pared to HEK293 cells. HCT116 cells transfected with control shRNA or
Hip2 shRNA were exposed to 5 Gy irradiation and cell cycle distribu-
tion was examined by FACS. Irradiation of cells resulted in an increase
in G2/M cell cycle arrest in Hip2-depleted cells (47%) compared to
control shRNA cells (37%) (Supplementary Fig. 2). Taken together,
Fig. 7.Hip2 ubiquitinates p53. (A) HEK293T cells were transiently co-transfected with ei-
ther pcDNA/HA or pcDNA/HA-Hip2, and pcDNA-p53. After 24 h, the cells were irradiated
with 5 Gy, incubated for an additional 16 h, and treated with 10 μMMG-132 for an addi-
tional 5 h. Cell lysates were analyzed byWestern blotting and probed with anti-p53 anti-
body. (B) HCT116 (p53+/+) cells were transiently co-transfectedwith either pcDNA/HA,
pcDNA/HA-Hip2, or pcDNA/HA-Hip2 (S86Y), and pcDNA/HA-Ub. The cells were exposed
to 5 Gy irradiation and then treated with 10 μM MG-132 for an additional 5 h. The cell
lysates were immunoprecipitated with anti-p53 antibody and bound proteins were
analyzed by Western blotting against an anti-ubiquitin antibody.
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cell cycle arrest.
The G2/M checkpoint regulators Cyclin B1 and p-Cdc2 are markers
of G2/M cell cycle arrest induced by DNA damage, and their expression
levels were therefore investigated in irradiated HEK293 cells in
the presence or absence of Hip2. The pcDNA/HA or pcDNA/HA-Hip2
vectors were transfected into HEK293 cells. After exposure to various
doses of irradiation, the levels of Cyclin B1 and p-Cdc2 proteins (Cdc2-
Tyr15 phosphorylation) were determined by Western blot analysis.
Band intensities weremeasured usingMulti-Gauge image analysis soft-
ware. As shown in Fig. 3A, cyclin B1 and p-Cdc2 protein levels increased
in response to irradiation in control cells, indicating an increase in the
population of G2/M-arrested cells, whereas the expression levels of
these markers were signiﬁcantly reduced in Hip2-overexpressing cells,
suggesting progression to other cell cycle phases.
To conﬁrm this ﬁnding further, shRNA-mediated knock-down ex-
periments were performed. HEK293 cells were transfected with either
control shRNA or Hip2 shRNA. The expression level of Hip2 in cells
transfected with Hip2 shRNA is shown in Fig. 3B. Western blot analysis
showed increased levels of cyclin B1 and p-cdc2 proteins in cells de-
pleted of Hip2 after irradiation (Fig. 3B). Taken together, our molecular
analyses and ﬂow cytometric analyses revealed that Hip2 overcomes
G2/M cell cycle arrest.
3.3. Hip2 promotes mitotic entry following radiation-induced G2/M arrest
To examine further the role of radiation-induced Hip2 in promoting
the transition into mitosis, HEK293 cells were transfected with pcDNA/
HA or pcDNA/HA-Hip2 and then exposed to 5 Gy irradiation. The
cells were treated with the microtubule-destabilizing agent nocodazole
for an additional 3 h, which blocks the formation of metaphase spindles
and thereby delays cell division. The level of expression of the mitosis
marker p-H3 (histone H3 phosphorylated at Ser 10) [17] was investi-
gated by Western blot analysis. As shown in Fig. 4A, p-H3 protein
expression was up-regulated in Hip2-overexpressing cells compared
to control cells, indicating that Hip2 promotes re-entry of cells into
the mitosis phase. Because nocodazole prevented cell cycle progression
beyond metaphase, cells in this phase accumulated in the presence of
Hip2, which is in contrast with data in Fig. 2 and 3. To conﬁrm this
ﬁnding, we performed shRNA-mediated knock-down experiments by
transfecting HEK293 cells with control shRNA or Hip2 shRNA. The
cells were exposed to 5 Gy irradiation and treated with nocodazole for
an additional 3 h. The level of p-H3 was decreased in Hip2-depleted
cells compared to control shRNA cells (Fig. 4B). These results suggested
that Hip2 promotes mitotic entry following radiation-induced G2/M
arrest.
3.4. Hip2 regulates the radiation-induced expression of p53 via the ubiquitin
proteasome system
The tumor suppressor p53 plays important roles in DNA damage-
induced cellular responses, such as the activation of DNA repair pro-
teins, cell cycle arrest, and apoptosis. The stability of the p53 protein is
regulated by the ubiquitin proteasome system [18,19]. We explored
the role of p53 in re-entry into the cell cycle after irradiation. HEK293
cells were transiently transfected with pcDNA/HA or pcDNA/HA-Hip2,
exposed to radiation for 16 h, and p53 expression was examined by
Western blotting. Irradiation induced p53 expression, and Hip2 overex-
pression decreased the expression levels of the p53 protein (Fig. 5A). To
conﬁrm the changes in p53 expression levels after irradiation in the
presence or absence of Hip2, a mutant Hip2 (S86Y) was used, which
showed that p53 expression levels were increased after irradiation in
cells expressing the mutant Hip2, compared with Hip2-overexpressing
cells (Fig. 5B). These results indicate that both p53 and Hip2 play crucial
roles in the re-entry of cells into mitosis from radiation-induced G2/M
arrest.To further conﬁrm this ﬁnding, shRNA-mediated knock-down ex-
periments were performed. HCT116 (p53+/+) cells were transfected
with GFP shRNA (control) or Hip2 shRNA. The expression levels of
Hip2 in cells transfected with Hip2 shRNA are shown in Supplementary
Fig. 3, left panel. Western blot results showed increased levels of
p53 and p21 in cells depleted of Hip2 after irradiation, indicating that
expression of p21, the product of a target gene of p53, is affected by
the presence of Hip2.
To investigate whether Hip2 interacts with p53 in vivo, co-
immunoprecipitation experiments were performed using HEK293T
cells transiently co-transfected with plasmid constructs containing
pcDNA/p53, pcDNA/GST, or pcDNA/GST-Hip2. Extracts of the transfected
cells were incubated with glutathione Sepharose beads, and proteins
bound to the beads were precipitated and probed with anti-p53 anti-
body. As shown in Fig. 6A, p53 interactedwithGST-Hip2. This interaction
was further conﬁrmed by performing binding assays with GST, GST-p53,
and pcDNA/GFP-Hip2 constructs expressed in HEK293T cells. Cell ex-
tracts were prepared and incubated with glutathione Sepharose beads
for 3 h. The bound proteins were eluted, subjected to SDS-PAGE, and an-
alyzed by Western blotting with anti-GFP antibodies. The GFP-tagged
Hip2 proteins interacted with the GST-p53 protein but not with GST
alone (Fig. 6B).
To visualize the interaction of p53 with Hip2, the two proteins were
fused to non-ﬂuorescent fragments of Cerulean (1–172) and ECFP
(155–238), respectively. Interaction of Hip2 with p53 would bring the
non-ﬂuorescent fragments into contact, resulting in the reconstruction
of the functional ﬂuorescent protein, as shown in Fig. 6C. HeLa cells
co-transfected with either pBiFC-CC155-Hip2 or pBiFC-CC155-Hip2
(S86Y), and pBiFC-CrN173-p53were visualized by Confocal Microscopy
with live cell imaging chambers. Cells co-transfectedwith pBiFC-CC155-
2919Y. Bae et al. / Biochimica et Biophysica Acta 1833 (2013) 2911–2921Hip2 and pBiFC-CrN173-p53 showed cerulean ﬂuorescence, which was
not observed in cells with other plasmid combinations (Fig. 6D),
conﬁrming that Hip2 interacted with p53.
The direct interaction between Hip2 and p53 indicated that Hip2
may promote the degradation of p53 through the ubiquitin proteasome
pathway. The stability of p53was examined in HCT116 cells transfected
with a plasmid containing HA-Hip2. After 24 h, the cells were exposed
to 5 Gy irradiation, incubated for an additional 16 h, and treated with
the proteasome inhibitor MG-132 for an additional 5 h. HA-Hip2
overexpression decreased the level of p53 (Fig. 7A).
The potential role of Hip2 in the degradation of p53 through the
proteasome pathway was further examined by performing in vivo
ubiquitination assays. HCT116 (p53+/+) cells (Fig. 7B)were transfected
with constructs containing either pcDNA/HA-Hip2 or pcDNA/HA-Hip2
(S86Y), pcDNA/HA-Ub, and pcDNA/Xpress-Ub. After 36 h, the cells
were exposed to 5 Gy radiation. To block the degradation of p53, cells
were immediately treated with MG-132 for an additional 5 h. The cell
extracts were immunoprecipitated with anti-p53 antibodies and ana-
lyzed by Western blotting with anti-Ub antibody. As shown in Fig. 7B,
the ubiquitinated p53 protein was present in cells overexpressing
Hip2, whereas its level was signiﬁcantly decreased in control and Hip2
(S86Y) mutant cells. These results indicated that Hip2 promotes p53
degradation via the ubiquitin proteasome pathway following ionizing
radiation.
The possible p53 dependence of the effect of Hip2 on overcoming
radiation-induced G2/M arrest was examined in HCT116 (p53−/−)
cells and HCT116 (p53+/+) cells. p53 was not expressed in HCT116
(p53−/−) cells (Supplementary Fig. 4A). Expression of p21, theFig. 8.Hip2 overcomes the radiation-induced G2/Marrest in a p53-dependentmanner. HCT116
or Hip2 shRNA using the PEI method. After 36 h, cells were irradiated with 5 Gy and cultured fo
panel. Cell cycle distribution was investigated using FACS analysis of DNA fragmentation in proproduct of a target gene of p53, was very low and was not affected by
the presence of Hip2. In addition, assays for cdc2 kinase activity were
performed using the histone H1 substrate. As shown in Supplementary
Fig. 4B, cdc2 kinase activity was higher in HCT116 (p53+/+) cells
overexpressing Hip2 than in those transfected with the control vector,
whereas an inverse relation was observed in HCT116 (p53−/−) cells.
To conﬁrm further that the effect of Hip2 is p53-dependent, we com-
pared cell cycle distribution between HCT116 (p53−/−) cells and
HCT116 (p53+/+) cells (Fig. 8). Hip2 shRNA-mediated knock-down
experiments were performed. HCT116 (p53−/−) cells and HCT116
(p53+/+) cells transfected with control shRNA or Hip2 shRNA were
exposed to 5 Gy irradiation, and cell cycle distribution was examined
by FACS. Irradiation of HCT116 (p53+/+) increased G2/M cell cycle ar-
rest in Hip2-depleted cells (78%) compared to control shRNA cells
(54%). In HCT116 (p53−/−) cells, however, the effect of Hip2 in over-
coming the radiation-induced G2/M arrest was signiﬁcantly decreased
(Hip2 shRNA cells, 42% vs. control shRNA cells, 38%). Taken together,
these results conﬁrm that the effect of Hip2 in overcoming the
radiation-induced G2/M arrest is p53-dependent.4. Discussion
The results of the present study show that Hip2 overcomes theG2/M
cell cycle arrest caused by ionizing radiation. The ubiquitin-conjugating
enzyme Hip2 regulates G2/M arrest in a p53-dependent manner by
targeting p53 for degradation by the ubiquitin proteasome system. The
present results provide important information for the understanding(p53+/+) cells (A) andHCT116 (p53−/−) cells (B)were transfectedwith control shRNA
r an additional 22 h. The knock-down levels of the HA-Hip2 proteins are shown in the top
pidium iodide-stained nuclei.
Fig. 8 (continued).
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arrest.
The tumor suppressor p53 is well known as a cell cycle regulator.
Chromosome damage caused by ionizing radiation stress induces the
phosphorylation of p53. Phosphorylated p53 does not bind to the E3
ligase Mdm2, resulting in the protection of p53 from Mdm2-mediated
degradation [20,21]. Subsequently, the up-regulated p53 protein
induces G2/M cell cycle arrest, thereby allowing the damaged chromo-
somes to be repaired before the cells enter into the mitosis phase. The
present results (Fig. 5) showed a decrease in the levels of radiation-
induced p53 protein in Hip2-overexpressing cells, which enabled the
cells to overcome the G2/M cell cycle arrest and progress to mitosis.
The results of co-immunoprecipitation, BiFC assays, and ubiquitination
assays revealed that Hip2 interacts with the tumor suppressor p53
and targets the protein for degradation (Fig. 7). Previously, Saville and
his colleagues reported that E2-25K/Hip2 as well as UbcH5A, UbcH5B,
and UbcH5C support Mdm2-mediated ubiquitination of p53, although
the ubiquitination level is lower with E2-25K/Hip2 [22]. We examined
whether Mdm-2 is a cognate E3 to the Hip2 E2 enzyme and found
that Hip2 interactedwithMdm-2 (Supplementary Fig. 5), and exposure
of cells to 5 Gy of irradiation strengthened the interaction. The effect of
this interaction on the Hip2 mediated-p53 degradation pathway is cur-
rently being investigated. To date, we have not found other E3 ligases
associated with Hip2 in the p53 degradation pathway. Indeed, previous
studies showed that Hip2 can successfully function as an E2 ubiquitin-
conjugating enzyme in the absence of E3 ligases [23], suggesting that
the degradation of p53 induced by Hip2 could also occur in the absence
of E3s.Previously, we reported that Hip2 promotes the degradation of
cyclin B1 through the ubiquitin proteasome pathway [12]. Cyclin B1
begins to increase during G2 and is rapidly degraded by the APC before
the cell cycle is complete.We speculate thatHip2 alsomight be involved
in the degradation of cyclin B1, which would be helpful for mitotic exit
and completion of the cell cycle.
The increase in the levels of Hip2 triggered by ionizing radiation oc-
curred at the protein level and not at the mRNA level. This increase was
mediated by the stabilization of Hip2 through the inhibition of its degra-
dation, as seen in the increase in the half-life of this protein from less
than 1 h tomuchmore than 2 h. This quick protein response to external
stimuli might be more efﬁcient for cell survival than mRNA responses.
However, the precise mechanism underlying the stabilization of Hip2
by ionizing radiation remains unclear.
In response to irradiation, mammalian cells induce cell cycle
arrest, thereby allowing the damaged chromosomes to be repaired
before the cells enter into the mitosis phase [24]. The present study
showed that Hip2 overcomes the G2/M cell cycle arrest caused by
ionizing radiation to enable cells to progress to mitosis. It is not
clear whether Hip2 is involved after or before the damaged chromo-
somes are repaired. If cell cycle progression induced by Hip2 occurs
without repair of DNA damage, the cells may develop into cancer
or other severe disease-related cells. Interestingly, Kikuchi et al. re-
ported that Hip2 (LIG) may contribute to foam cell formation
through ubiquitination and subsequent degradation of p53, which
promotes the development of atherosclerosis [25].
The present study demonstrated that Hip2 plays a novel role in
the transition of the cell through the G2/M DNA damage checkpoint
2921Y. Bae et al. / Biochimica et Biophysica Acta 1833 (2013) 2911–2921and the regulation of the entry into mitosis. Radiation-induced Hip2
affects the p53-mediated cell cycle checkpoints by modulating the
ubiquitination and proteasomal degradation of p53. The present results
provide important information for our understanding of the role of Hip2
in cell cycle progression in response to ionizing radiation, and suggest
a new approach to cancer therapy involving Hip2.
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